Study finds transdermal continuous oxygen therapy reduces inflammatory cytokines

11/12/2013 | Ostomy Wound Management online

Patients with chronic diabetic foot ulcers who received transdermal continuous oxygen therapy, in addition to standard care, for four weeks had lower levels of pro-inflammatory cytokines and tissue-degrading proteases than patients treated with standard care alone in a small study. Average wound size was reduced 87% in the oxygen therapy group compared with 46% in the control group, the researchers report.

View Full Article in:

Ostomy Wound Management online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park